Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Apr 30, 2025 | (FY)Oct 31, 2024 | (Q6)Apr 30, 2024 | (FY)Oct 31, 2023 | (Q6)Apr 30, 2023 | (FY)Oct 31, 2022 | (Q6)Apr 30, 2022 | (FY)Oct 31, 2021 | (Q6)Apr 30, 2021 | (FY)Oct 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 17.93%3.47B | 18.75%6.33B | 18.00%2.94B | 17.33%5.33B | 6.33%2.49B | 12.07%4.54B | 25.00%2.34B | 17.85%4.05B | 0.42%1.88B | -31.47%3.44B |
| Operating income | 17.93%3.47B | 18.75%6.33B | 18.00%2.94B | 17.33%5.33B | 6.33%2.49B | 12.07%4.54B | 25.00%2.34B | 17.85%4.05B | 0.42%1.88B | -31.47%3.44B |
| Cost of sales | -19.55%-2.47B | -17.33%-4.38B | -15.62%-2.07B | -17.45%-3.74B | -5.10%-1.79B | -10.83%-3.18B | -27.18%-1.7B | -24.14%-2.87B | -6.99%-1.34B | 33.76%-2.31B |
| Operating expenses | -19.55%-2.47B | -17.33%-4.38B | -15.62%-2.07B | -17.45%-3.74B | -5.10%-1.79B | -10.83%-3.18B | -27.18%-1.7B | -24.14%-2.87B | -6.99%-1.34B | 33.76%-2.31B |
| Gross profit | 14.06%994.43M | 22.10%1.94B | 24.06%871.86M | 17.04%1.59B | 9.61%702.76M | 15.08%1.36B | 19.54%641.15M | 4.92%1.18B | -12.95%536.35M | -26.21%1.13B |
| Selling expenses | -11.66%-394.36M | -23.50%-818.28M | -15.91%-353.17M | -10.68%-662.56M | -4.61%-304.69M | -2.89%-598.6M | -1.27%-291.26M | 0.75%-581.79M | 7.81%-287.61M | 11.09%-586.19M |
| Administrative expenses | -3.10%-379.16M | -17.96%-745.87M | -29.18%-367.76M | -7.04%-632.3M | -3.04%-284.69M | -3.88%-590.74M | -20.27%-276.3M | -5.62%-568.67M | 13.20%-229.74M | 12.03%-538.4M |
| Depreciation and amortization | 8.20%-12.06M | 18.52%-25.22M | 20.28%-13.13M | 21.52%-30.96M | 17.32%-16.48M | 0.46%-39.45M | -0.68%-19.93M | 0.01%-39.63M | 0.31%-19.79M | -27.92%-39.63M |
| Revaluation surplus | ---- | 6,366.67%376K | ---- | -100.02%-6K | ---- | -27.29%33.54M | 2,675.44%33.46M | 138.47%46.13M | 88.72%-1.3M | 146.25%19.34M |
| Impairment and provision | 45.90%-6.84M | -40.49%-49.27M | -50.99%-12.64M | 19.93%-35.07M | -4.90%-8.37M | -52.38%-43.8M | -68.58%-7.98M | -56.08%-28.74M | -209.08%-4.73M | -44.94%-18.42M |
| -Other impairment is provision | 45.90%-6.84M | -40.49%-49.27M | -50.99%-12.64M | 19.93%-35.07M | -4.90%-8.37M | -52.38%-43.8M | -68.58%-7.98M | -56.08%-28.74M | -209.08%-4.73M | -44.94%-18.42M |
| Special items of operating profit | -48.24%66.77M | 71.97%170.73M | 87.50%129.01M | 19.67%99.28M | 355.17%68.8M | -49.39%82.96M | -80.58%15.12M | 23.63%163.94M | 67.90%77.82M | -10.55%132.61M |
| Operating profit | 5.76%268.79M | 44.25%474.56M | 61.54%254.16M | 62.07%328.99M | 66.91%157.33M | 17.90%202.99M | 32.77%94.26M | 81.53%172.17M | 34.14%71M | -70.05%94.85M |
| Financing cost | 8.24%-14.84M | 16.93%-33.42M | 21.40%-16.18M | -82.06%-40.23M | -137.07%-20.58M | -21.23%-22.1M | 10.07%-8.68M | 25.76%-18.23M | 29.02%-9.65M | -99.80%-24.55M |
| Share of profits of associates | 401.61%4.35M | 1.28%11.61M | 220.75%867K | 296.20%11.46M | 82.22%-718K | 11.96%2.89M | 59.88%-4.04M | 123.51%2.58M | -26.07%-10.06M | -176.58%-10.99M |
| Share of profit from joint venture company | -52.03%389K | 63.96%1.49M | 426.62%811K | 307.76%910K | 15,500.00%154K | ---438K | ---1K | ---- | ---- | ---- |
| Earning before tax | 7.94%258.68M | 50.85%454.24M | 75.98%239.66M | 64.24%301.13M | 67.02%136.19M | 17.13%183.35M | 59.01%81.54M | 163.95%156.53M | 63.59%51.28M | -81.39%59.3M |
| Tax | -28.15%-52.35M | -50.21%-86.22M | -20.84%-40.85M | -92.98%-57.4M | -134.99%-33.8M | -16.60%-29.74M | -94.10%-14.39M | -660.33%-25.51M | -20.15%-7.41M | 93.86%-3.36M |
| After-tax profit from continuing operations | 3.79%206.34M | 51.00%368.02M | 94.18%198.81M | 58.68%243.73M | 52.46%102.39M | 17.23%153.6M | 53.09%67.15M | 134.18%131.02M | 74.23%43.87M | -78.82%55.95M |
| Earning after tax | 3.79%206.34M | 51.00%368.02M | 94.18%198.81M | 58.68%243.73M | 52.46%102.39M | 17.23%153.6M | 53.09%67.15M | 134.18%131.02M | 74.23%43.87M | -78.82%55.95M |
| Minority profit | -184.34%-6M | -33.19%10.46M | 457.93%7.11M | 273.08%15.65M | 172.76%1.27M | -53.55%-9.04M | 87.18%-1.75M | -208.78%-5.89M | -1,395.64%-13.66M | -25.87%5.41M |
| Profit attributable to shareholders | 10.76%212.33M | 56.77%357.57M | 89.59%191.7M | 40.24%228.08M | 46.74%101.11M | 18.80%162.64M | 19.79%68.91M | 170.91%136.91M | 138.46%57.52M | -80.32%50.54M |
| Basic earnings per share | 10.28%0.1706 | 56.65%0.2884 | 89.35%0.1547 | 40.21%0.1841 | 46.94%0.0817 | 18.72%0.1313 | 19.57%0.0556 | 171.08%0.1106 | 138.46%0.0465 | -80.35%0.0408 |
| Diluted earnings per share | 10.23%0.1703 | 56.28%0.2874 | 89.34%0.1545 | 40.06%0.1839 | 46.76%0.0816 | 18.82%0.1313 | 19.57%0.0556 | 170.83%0.1105 | 138.46%0.0465 | -80.35%0.0408 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.